Edmund Harrigan - Net Worth and Insider Trading

Edmund Harrigan Net Worth

The estimated net worth of Edmund Harrigan is at least $11 Million dollars as of 2022-12-08. Edmund Harrigan is the Director of Karuna Therapeutics Inc and owns about 55,163 shares of Karuna Therapeutics Inc (KRTX) stock worth over $11 Million. Edmund Harrigan is the Director of ACADIA Pharmaceuticals Inc and owns about 1,000 shares of ACADIA Pharmaceuticals Inc (ACAD) stock worth over $14,630. Edmund Harrigan is also the Director of PhaseBio Pharmaceuticals Inc and owns about 6,000 shares of PhaseBio Pharmaceuticals Inc (PHASQ) stock worth over $270. Details can be seen in Edmund Harrigan's Latest Holdings Summary section.

Transaction Summary of Edmund Harrigan

To

Edmund Harrigan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Edmund Harrigan owns 5 companies in total, including Incyte Corp (INCY) , Karuna Therapeutics Inc (KRTX) , and ACADIA Pharmaceuticals Inc (ACAD) among others .

Click here to see the complete history of Edmund Harrigan’s form 4 insider trades.

Insider Ownership Summary of Edmund Harrigan

Ticker Comapny Transaction Date Type of Owner
INCY Incyte Corp 2019-12-16 director
KRTX Karuna Therapeutics Inc 2019-06-27 director
ACAD ACADIA Pharmaceuticals Inc 2019-06-26 director
PHASQ PhaseBio Pharmaceuticals Inc 2020-06-03 director
BLCM Bellicum Pharmaceuticals Inc 2018-02-20 director

Edmund Harrigan Latest Holdings Summary

Edmund Harrigan currently owns a total of 3 stocks. Among these stocks, Edmund Harrigan owns 55,163 shares of Karuna Therapeutics Inc (KRTX) as of August 12, 2020, with a value of $11 Million and a weighting of 99.87%. Edmund Harrigan owns 1,000 shares of ACADIA Pharmaceuticals Inc (ACAD) as of August 16, 2016, with a value of $14,630 and a weighting of 0.13%. Edmund Harrigan also owns 6,000 shares of PhaseBio Pharmaceuticals Inc (PHASQ) as of December 3, 2020, with a value of $270 and a weighting of 0%.

Latest Holdings of Edmund Harrigan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KRTX Karuna Therapeutics Inc 2020-08-12 55,163 202.10 11,148,442
ACAD ACADIA Pharmaceuticals Inc 2016-08-16 1,000 14.63 14,630
PHASQ PhaseBio Pharmaceuticals Inc 2020-12-03 6,000 0.05 270

Holding Weightings of Edmund Harrigan


Edmund Harrigan Form 4 Trading Tracker

According to the SEC Form 4 filings, Edmund Harrigan has made a total of 3 transactions in Karuna Therapeutics Inc (KRTX) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Karuna Therapeutics Inc is the sale of 10,000 shares on August 12, 2020, which brought Edmund Harrigan around $833,200.

According to the SEC Form 4 filings, Edmund Harrigan has made a total of 0 transactions in ACADIA Pharmaceuticals Inc (ACAD) over the past 5 years. The most-recent trade in ACADIA Pharmaceuticals Inc is the acquisition of 1,000 shares on August 16, 2016, which cost Edmund Harrigan around $32,970.

According to the SEC Form 4 filings, Edmund Harrigan has made a total of 1 transactions in PhaseBio Pharmaceuticals Inc (PHASQ) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in PhaseBio Pharmaceuticals Inc is the acquisition of 6,000 shares on December 3, 2020, which cost Edmund Harrigan around $24,720.

Insider Trading History of Edmund Harrigan

Ticker Company Date Buy/Sell Insider Trading Shares Shares Change Price Cost Final Share Current Price Price Change Since Insider Trade (%) Filing Date
PHASQ
PhaseBio Pharmaceuticals Inc
2020-12-03 Buy
6,000.00
100.00%
$4.12
$24,720.00
6,000.00
$0.04
-98.91%
-
KRTX
Karuna Therapeutics Inc
2020-08-12 Sell
10,000.00
-15.35%
$83.32
$833,200.00
55,163.00
$202.10
142.56%
-
KRTX
Karuna Therapeutics Inc
2020-07-13 Sell
10,000.00
-13.30%
$93.40
$934,000.00
65,163.00
$202.10
116.38%
-
KRTX
Karuna Therapeutics Inc
2020-06-12 Sell
30,000.00
-28.53%
$91.79
$2,753,700.00
75,163.00
$202.10
120.18%
-
ACAD
ACADIA Pharmaceuticals Inc
2016-08-16 Buy
1,000.00
100.00%
$32.97
$32,970.00
1,000.00
$14.63
-55.63%
-
Total 5
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Edmund Harrigan Trading Performance

GuruFocus tracks the stock performance after each of Edmund Harrigan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Edmund Harrigan is -10.06%. GuruFocus also compares Edmund Harrigan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Edmund Harrigan within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Edmund Harrigan's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Edmund Harrigan

Average Relative Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) -6.18 -10.06 3.74 -27.68 -62.47 -2.93
Relative Return to S&P 500(%) -6.5 -12.11 -7.32 -46.22 -72.26 -12.8

Edmund Harrigan Ownership Network

Ownership Network List of Edmund Harrigan

No Data

Ownership Network Relation of Edmund Harrigan


Edmund Harrigan Owned Company Details


Edmund Harrigan Mailing Address

Above is the net worth, insider trading, and ownership report for Edmund Harrigan. Currently GuruFocus does not have mailing address information for Edmund Harrigan.